Cargando…
Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes
Ewing Sarcoma is an aggressive malignancy of bone and soft tissue affecting children and young adults. Ewing Sarcoma is driven by EWS/Ets fusion oncoproteins, which cause widespread alterations in gene expression in the cell. Dysregulation of receptor tyrosine kinase signaling, particularly involvin...
Autores principales: | Niemeyer, Brian F., Parrish, Janet K., Spoelstra, Nicole S., Joyal, Teresa, Richer, Jennifer K., Jedlicka, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300218/ https://www.ncbi.nlm.nih.gov/pubmed/25603314 http://dx.doi.org/10.1371/journal.pone.0116895 |
Ejemplares similares
-
Correction: Variable Expression of PIK3R3 and PTEN in Ewing Sarcoma Impacts Oncogenic Phenotypes
Publicado: (2015) -
MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth
por: Moore, Colin, et al.
Publicado: (2017) -
The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
por: Sechler, Marybeth, et al.
Publicado: (2017) -
MicroRNAs in Ewing Sarcoma
por: Dylla, Layne, et al.
Publicado: (2013) -
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
por: Parrish, Janet K., et al.
Publicado: (2018)